Biliary Tract Cancer Updates: Advancements and Insights
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Gastrointestinal Oncology".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 140
Special Issue Editor
Interests: bile duct cancer; biliary cancer; colorectal cancer; gastrointestinal cancer; gastrointestinal neuroendocrine tumor; liver cancer; pancreatic cancer
Special Issue Information
Dear Colleagues,
Welcome to the inaugural edition of “Biliary Tract Cancer Updates: Advancements and Insights”. Biliary tract cancers, encompassing malignancies of the bile ducts, gallbladder, and ampulla of Vater, present formidable challenges in diagnosis, treatment, and management. Despite recent advances, these cancers remain notoriously difficult to detect at early stages and in advanced stages continue to pose significant clinical dilemmas that necessitate novel approaches to management. This Special Issue of Current Oncology serves as a platform for disseminating cutting-edge research, clinical breakthroughs, and multidisciplinary perspectives in this rapidly evolving field. With this Special Issue, we aim to bridge the gap between scientific discoveries and clinical practice by providing comprehensive updates on the latest developments in biliary tract cancer research and practice. Moreover, “Biliary Tract Cancer Updates” serves as a collaborative platform for researchers, clinicians, pathologists, and allied healthcare professionals to contribute to the collective knowledge base in this specialized field. We invite submissions from researchers and clinicians across diverse disciplines to contribute their original research, clinical insights, and perspectives to this Special Issue. Together, let us explore new horizons and pave the way for groundbreaking advancements in patient care.
Thank you for joining us on this journey of discovery and innovation in the fight against biliary tract cancers!
Warm Regards,
Dr. Kristen R. Spencer
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biliary tract cancer
- intrahepatic cholangiocarcinoma
- extrahepatic cholangiocarcinoma
- gallbladder cancer
- targeted therapy
- immunotherapy
- molecular profiling
- clinical trials
